Clinical Trials Directory

Trials / Completed

CompletedNCT04295343

Three-dimensional (3D) Rectal Water Contrast Transvaginal Ultrasonography Versus Computed Colonography in the Diagnosis of Rectosigmoid Endometriosis

Three-dimensional Rectal Water Contrast Transvaginal Ultrasonography Versus Computed Colonography in the Diagnosis of Rectosigmoid Endometriosis

Status
Completed
Phase
Study type
Observational
Enrollment
68 (actual)
Sponsor
Ospedale Policlinico San Martino · Academic / Other
Sex
Female
Age
18 Years
Healthy volunteers
Accepted

Summary

Rectosigmoid involvement by endometriosis causes intestinal symptoms such as constipation, diarrhea, and dyschezia. A non-invasive diagnosis of bowel endometriosis is relevant to provide the patients information on the potential hormonal or surgical treatments. The objective of the current study was to compare the performance of three-dimensional rectal water contrast transvaginal ultrasonography (3D-RWC-TVS) and computed colonography (CTC) in predicting the presence and characteristics of rectosigmoid endometriosis.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTThree-dimensional (3D) rectal water contrast transvaginal ultrasonographyRectal water contrast transvaginal ultrasonography is based on the distention of rectosigmoid with saline solution. Three-dimensional reconstructions convert standard 2D grayscale ultrasound acquisitions into a volumetric dataset.
DIAGNOSTIC_TESTComputed colonographyComputed colonography or virtual colonoscopy uses special x-ray equipment to examine the large intestine. During the exam, a small tube is inserted a short distance into the rectum to allow for inflation with gas while computed tomographic images of the colon and the rectum are taken.

Timeline

Start date
2017-03-01
Primary completion
2019-09-01
Completion
2020-02-01
First posted
2020-03-04
Last updated
2020-06-01

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT04295343. Inclusion in this directory is not an endorsement.